Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from cancer treatment is a major emotional burden for patients because it affects their appearance and constantly reminds them of their illness.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Alopecia, or hair loss, can be caused by genetics, illness, or certain drugs, and can be treated with synthetic or natural medications.

Different types of hair loss can be caused by hormones, stress, autoimmune disorders, illness, or nutritional deficiencies, and can be treated with medication, nutritional supplements, or hair transplantation.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

AI can predict hair loss patterns to improve care and treatment.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

Some plants might help prevent or treat hair loss.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

The document concludes that understanding hair problems can lead to cost-effective solutions and proper treatment choices.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

Certain diseases like AIDS and lupus can make African hair become silky.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Taking fluconazole for fungal infections might cause hair loss after about 3 months.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Long COVID causes lasting symptoms and needs ongoing care.